Rôle du pharmacien d’officine dans la prise en charge des maladies coronariennes

Abstract

Coronary artery disease, the most common form of heart disease, results from the gradual narrowing of the arteries that supply blood to the heart, caused by the buildup of atherosclerotic plaques. It is a widespread chronic condition, yet its progression can be controlled by managing risk factors, both in primary and secondary prevention. Drug therapies, combined with lifestyle and dietary measures, are essential to limit complications. Therefore, it is crucial for patients to understand and adhere to these measures. The community pharmacist, as a highly accessible healthcare professional, plays a central role in this regard. This work is based on two complementary field surveys: one conducted among coronary patients, and the other among community pharmacists. Its goal is to gain a deeper understanding of current support practices, patient expectations, and field-based limitations. The findings reveal that, despite a basic awareness of their treatment, many patients still lack knowledge about drug interactions and warning signs. As a medication expert, the pharmacist is perfectly positioned to fill these gaps by informing, guiding, reassuring, and preventing medication errors. However, the pharmacist’s role in therapeutic education remains underutilized and insufficiently recognized. With the growing burden of chronic diseases, this role is bound to become increasingly vital. In conclusion, this study highlights the need for a more active and structured involvement of pharmacists in the care of coronary patients. By asserting their full expertise, pharmacists can greatly contribute to improving patients’ quality of life and reducing complication